Drug Approval | October 01, 2024
Apitoria Pharma gets Form 483 with 10 observations from USFDA
The observations are of procedural in nature and will be responded to within the stipulated time
The observations are of procedural in nature and will be responded to within the stipulated time
The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
The special financing terms offered by United Imaging and structured by Medikabazaar to Krsnaa Diagnostics underscore the strategic importance of this alliance
The inspection concluded with the issuance of a form 483 with five observations
The net-zero target approval complements the company's near-term emission reduction targets
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for treatment of schizophrenia
The company will also share results in two additional posters for deuruxolitinib
Quinidine Sulphate helps manage rare irregular heartbeat conditions
This initiative aims to raise awareness about the importance of monitoring blood sugar levels before indulging in sweets
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
